Infectious Diseases
Research and Innovation Series

RECORDING: Randomized Trial of Single-Dose HPV Vaccination in Young Women: 54-Month Efficacy and Durability

Discover how the KEN SHE Study, led by Professor Ruanne Barnabas, demonstrates lasting protection from a single-dose HPV vaccine and highlights its potential to transform cervical cancer prevention and equity in global health.

Featuring:

  • Ruanne Barnabas, MBChB, PhD, Chief of the Division of Infectious Diseases at MGH; Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health
  • Moderator: Louise C. Ivers, MD, MPH, DTM&H, Faculty Director, Harvard Global Health Institute

Related Materials